ILMN

Illumina Inc

$193.00
0.27 (0.14%) Today
0.36 (0.19%) After-hours
Compare ILMN
Market Cap
$29.09B+90.5%
Revenue (TTM)
$4.44B+4.9%
Net Income (TTM)
$813.99M-31.9%
EPS (TTM)
5.38-31.9%
Shares Out
151.30M
P/E Ratio
34.73
Forward P/E
36.43
Open
$194.00
Previous Close
$192.91
Day Range
$187.44 – $194.50
52-Week Range
$88.00 – $207.00
Beta
1.43
Volume
1.06M
Avg Volume
1.85M
Analyst Rating
Buy
Exchange
NASDAQ NMS - GLOBAL MARKET

About ILMN

Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets, and serves more than 155 countries.

Related

News